Global Infusion Systems Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape

DUBLIN, Jan. 17, 2024 /PRNewswire/ — The “Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update” report has been added to ResearchAndMarkets.com’s offering.

Infusion Systems Pipeline Report provides comprehensive information about the Infusion Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Infusion systems are used to administer medication to a patient in critical care, emergency care, home care and trauma centres.

The report provides comprehensive coverage of the Infusion Systems currently under development, offering a deep dive into this vital healthcare sector. It meticulously examines the specifics of major pipeline products, encompassing thorough product descriptions, licensing agreements, collaboration details, and other essential developmental activities that are shaping the landscape of infusion systems.

Furthermore, the report scrutinizes the major players actively driving innovation in Infusion Systems, presenting a comprehensive catalog of their ongoing pipeline projects. This coverage spans the entire spectrum of development stages, ranging from early conceptualization to products in the approved and issued stages, delivering a holistic view of the evolving realm of infusion systems.

Additionally, the report furnishes essential clinical trial data pertinent to ongoing trials linked to these pipeline products. It also keeps stakeholders informed about the most recent developments within the infusion systems segment and the broader industry, ensuring that they stay abreast of the latest trends and advancements in this critical field.

Reasons to Buy

Formulate significant competitor information, analysis, and insights to improve R&D strategiesIdentify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantageIdentify and understand important and diverse types of Infusion Systems under developmentDevelop market-entry and market expansion strategiesPlan mergers and acquisitions effectively by identifying major players with the most promising pipelineIn-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Infusion Systems Overview

3 Products under Development
3.1 Infusion Systems – Pipeline Products by Stage of Development
3.2 Infusion Systems – Pipeline Products by Segment
3.3 Infusion Systems – Pipeline Products by Territory
3.4 Infusion Systems – Pipeline Products by Regulatory Path
3.5 Infusion Systems – Pipeline Products by Estimated Approval Date
3.6 Infusion Systems – Ongoing Clinical Trials

4 Infusion Systems – Pipeline Products under Development by Companies
4.1 Infusion Systems Companies – Pipeline Products by Stage of Development
4.2 Infusion Systems – Pipeline Products by Stage of Development

5 Infusion Systems Companies and Product Overview

6 Infusion Systems- Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

410 Medical IncAbbVie IncAcuros GmbHAdept Medical LtdAgitated Solutions LLCAlbireo Pharma IncAlnylam Pharmaceuticals IncArnali, LLCAvoset Health LtdBaxter Healthcare CorpBaxter International IncBecton Dickinson and CoBioQ Pharma IncClearLine MDCognos Therapeutics IncDebiotech SAEksigent Technologies, LLCEli Lilly and CoEryDel SPAFlowonix Medical IncFluid Synchrony LLCFluonic, Inc. (Inactive)Fresenius Medical Care AG & Co KGaAHAI Solutions IncHospira IncICU Medical IncInfusense CorpInnofuse BVInnovative Health Sciences LLCInnovfusion Pte. Ltd.Intarcia Therapeutics IncIRadimed CorpKORU Medical Systems IncLifeMedix, LLCLynntech IncMassachusetts Institute of TechnologyMedical Device Creations Ltd.Medovate LtdMonuMedical LLCNeurochase LtdNexGen Medical Systems IncPalyon Medical Corp (Inactive)Pavmed IncPRO-IV Medical LtdRatio IncRice UniversitySensile Medical AGShenox Pharmaceuticals LLCShift Labs IncSQ Innovation AGSree Chitra Tirunal Institute for Medical Sciences & TechnologyStarton Therapeutics IncSteadyMed Therapeutics IncStnDrd Infusion CorporationSupernus Pharmaceuticals IncTerumo CorpToucheMedical Ltd.TriSalus Life Sciences IncTurnpoint Medical Devices IncU-Needle BVUnilife CorporationUnited Therapeutics CorpUniversity of MinnesotaUniversity of Southern CaliforniaZealand Pharma AS

For more information about this report visit https://www.researchandmarkets.com/r/io5tb6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/global-infusion-systems-clinical-pipeline-research-report-2023-stages-of-development-segments-region-and-countries-regulatory-path-and-competitive-landscape-302036894.html

SOURCE Research and Markets